Company intelligence / Profile preview

Shanghai Sai'ao Biotechnology

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shanghai Sai'ao Biotechnology is a Chinese biopharmaceutical company specializing in the research, development, and large-scale production of recombinant protein therapeutics. The company is best known for its production of recombinant human interferon alpha-2b (IFNα-2b), which is marketed for the treatment of viral infections such as Hepatitis B and C, as well as certain types of cancer. Operating out of the Shanghai Zhangjiang Hi-Tech Park, the firm maintains high-standard GMP manufacturing facilities to support its commercialized biologics portfolio. Its business model integrates R&D with industrial-scale manufacturing to serve the domestic Chinese healthcare market.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Recombinant proteinBiologicCytokine
Industry: Biotech

Beyond the preview

Go deeper on Shanghai Sai'ao Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Sai'ao Biotechnology.

Explore the full profile